Did you mean: Pilar El Dos Santos-Gallego
GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia
…, AI Martínez-Vidal, PR Dosantos-Gallego… - MedRxiv, 2020 - medrxiv.org
Background We aimed to determine whether a 6-day course of intravenous methylprednisolone
(MP) improves outcome in patients with SARS CoV-2 infection at risk of developing …
(MP) improves outcome in patients with SARS CoV-2 infection at risk of developing …
[HTML][HTML] Methylprednisolone in adults hospitalized with COVID-19 pneumonia: An open-label randomized trial (GLUCOCOVID)
L Corral-Gudino, A Bahamonde… - Wiener klinische …, 2021 - Springer
Purpose To determine whether a 6-day course of methylprednisolone (MP) improves outcome
in patients with severe SARS-CoV‑2 (Corona Virus Disease 2019 [COVID-19]). Methods …
in patients with severe SARS-CoV‑2 (Corona Virus Disease 2019 [COVID-19]). Methods …